Table 2.
Literature review of 1980–2012: management of infected prosthetic knee joints with debridement/retention
| First author | No. of prostheses | Main pathogen | Arthrotomy (vs arthroscopy) | Duration of antibiotic treatment | Remission | Minimal follow-up |
|---|---|---|---|---|---|---|
| Teeny [2] | 21 | MSSA | – | 0.7–2 months | 6 (29 %) | 12 months |
| Bradbury [3] | 19 | MRSA | 19 (100 %) | 1.0–1.5 months | 3 (16 %) | 24 months |
| Dixon [4] | 15 | MSSA | 0 (0 %) | 3–16 months | 9 (60 %) | 4 months |
| Deirmengian [5] | 31 | MSSA | 31 (100 %) | 1.5 months | 11 (35 %) | 24 months |
| Woods [6] | 27 | MSSA | – | 1.0–1.5 months | 3 (11 %) | 36 months |
| Aboltins [7] | 7 | MSSA/MRSA | 7 (100 %) | 12 months | 6 (86 %) | 12 months |
| Ilahi [8] | 5 | Streptococci | 0 (0 %) | 2.0–2.5 months | 5 (100 %) | 36 months |
| Barberán [9] | 28 | CoNS | – | 1.5–3 months | 19 (68 %) | 12 months |
| Byren [10] | 51 | MSSA | - | 18 months | 38 (75 %) | 3 months |
| Cobo [11] | 46 | MSSA | – | 1.5–3 months | 29 (63 %) | 0 month |
| Vidil [13] | 5 | MSSA | 0 (0 %) | 3 months | 2 (40 %) | 6 months |
| Waldman [14] | 16 | MSSA | 0 (0 %) | 1.5 months | 6 (38 %) | 36 months |
| Siddiqui [15] | 12 | MRSA | 12 (100 %) | 1.5 months | 4 (33 %) | 24 months |
| Meehan [16] | 13 | Streptococci | – | 0.5–1.2 months | 12 (92 %) | 4 months |
| Schoifet [17] | 31 | MRSA | 31 (100 %) | 2 months | 7 (23 %) | 7 months |
| Freeman [18] | 6 | MSSA | – | 3 months | 5 (83 %) | 12 months |
| Flood [19] | 2 | MSSA | 0 (0 %) | – | 2 (100 %) | 30 months |
| Tsumura [20] | 9 | MRSA | 0 (0 %) | – | 7 (78 %) | 13 months |
| Burger [22] | 39 | MSSA | 39 (100 %) | 0.5–2 months | 7 (18 %) | 12 months |
| Chiu [23] | 40 | MRSA | 40 (100 %) | 1.5 months | 12 (30 %) | 36 months |
| Tattevin [25] | 34 | MSSA | – | – | 13 (38 %) | 12 months |
| Hartman [26] | 33 | MSSA | 32 (97 %) | 0.5–3 months | 20 (61 %) | – |
| Rasul [27] | 10 | CoNS | – | 1.0–1.5 months | 4 (40 %) | 24 months |
| Mont [28] | 24 | MSSA | 24 (100 %) | 1.5–3 months | 20 (83 %) | 48 months |
| Wilson [29] | 31 | MSSA | 23 (74 %) | – | 17 (55 %) | 24 months |
| Borden [30] | 11 | MSSA | – | – | 5 (45 %) | – |
| Grogan [31] | 12 | MSSA | 5 (42 %) | – | 5 (42 %) | 18 months |
| This article | 21 | MSSA | 11 (55 %) | 1.5–3 months | 7 (33 %) | 24 months |
| Total/average | 599 | MSSA | 274 (46 %) | 2 months | 284 (47 %) | 19 months |
MSSA methicillin-sensitive Staphylococcus aureus, MRSA methicillin-resistant Staphylococcus aureus, CoNS coagulase-negative staphylococci